Fundz

Engrail Therapeutics Raises $32 Million in Series A Financing

PRIVATEJun 18, 2020

Amount Raised

$32 Million

Round Type

Series A

San DiegoBiotechnologyHealth CareTherapeutics

Description

Engrail Therapeutics™ (Engrail) (the Company) today announced the close of a $32 million Series A financing round. Nan Fung Life Sciences (NFLS), the global investment platform of the Nan Fung Group, led the round. The Company plans to use the proceeds from the financing to support the clinical development of its first pipeline asset, ENX-101, a sub-type selective GABA A modulator.

Quick answer

Engrail Therapeutics raised $32 Million in a Series A round, dated June 18, 2020. Engrail Therapeutics is based in San Diego, California, United States.

How much did Engrail Therapeutics raise?
Engrail Therapeutics raised $32 Million in a Series A round on June 18, 2020.
What does Engrail Therapeutics do?
Engrail Therapeutics is a precision neuroscience company focused on developing transformational therapies to improve the lives of patients with neuropsychiatric and neurodevelopmental diseases.
Where is Engrail Therapeutics based and how big is it?
Engrail Therapeutics is based in San Diego, California, United States.
Who are the decision-makers at Engrail Therapeutics?
Fundz holds 1 contact at Engrail Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Engrail Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • MBX Biosciences, Inc. raised $34M (Series A) on July 27, 2020.
  • MBX Biosciences, Inc. raised $26M on July 27, 2020.
  • Lisata Therapeutics raised $2M (Seed) on July 27, 2020.
  • Nanoscope Therapeutics raised $13M on July 22, 2020.
  • Artiva Biotherapeutics raised $43M on July 10, 2020.
  • Vor Bio raised $110M on July 10, 2020.

Who to call at Engrail Therapeutics, and when

A new round usually means Engrail Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Engrail Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Engrail Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Engrail Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Engrail Therapeutics

Location

San Diego, California, United States

About

Engrail Therapeutics is a precision neuroscience company focused on developing transformational therapies to improve the lives of patients with neuropsychiatric and neurodevelopmental diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Engrail Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Engrail Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Engrail Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.